Medexus Pharmaceuticals Inc. (P731)
Market Closed
12 Dec, 20:00
XBER 
€
1. 62
0
0%
€
39.72M Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
€ 1.62
Previous Close Day Range
1.6 1.64
Year Range
1.3 3.34
Want to track P731 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 53 days
Summary
P731 closed Friday higher at €1.62, an increase of 0% from Thursday's close, completing a monthly decrease of -6.9% or €0.12. Over the past 12 months, P731 stock lost -30.77%.
P731 is not paying dividends to its shareholders.
The last earnings report, released on Nov 12, 2025, exceeded the consensus estimates by 0.03%. On average, the company has surpassed earnings expectations by 0.03%, based on the last three reports. The next scheduled earnings report is due on Feb 05, 2026.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on TSX (CAD).
Medexus Pharmaceuticals Inc. (P731) FAQ
What is the stock price today?
The current price is €1.62.
On which exchange is it traded?
Medexus Pharmaceuticals Inc. is listed on TSX.
What is its stock symbol?
The ticker symbol is P731.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0%.
What is its market cap?
As of today, the market cap is 39.72M.
When is the next earnings date?
The next earnings report will release on Feb 05, 2026.
Has Medexus Pharmaceuticals Inc. ever had a stock split?
No, there has never been a stock split.
Medexus Pharmaceuticals Inc. Profile
| Health Care Technology Industry | Healthcare Sector | - CEO | XBER Exchange | CA58410Q2036 ISIN |
| Germany Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Contact Information
Address: -
Phone: -
2025 © Marketlog. All Rights Reserved.
